PA GOODDOCTOR (01833) Reports H1 2025 Revenue of 2.5 Billion Yuan, Net Profit Surges 136.8%

Stock News
Aug 19

On August 19, 2025, Ping An Healthcare and Technology Company Limited (stock name "PA GOODDOCTOR", 01833, hereinafter referred to as "the Company") announced its interim results for the six months ended June 30, 2025. The data shows that the company maintained steady overall operations with strong growth momentum, achieving dual improvements in revenue and profitability.

During the reporting period, the company recorded total revenue of 2.5 billion yuan, representing a year-on-year increase of 19.5%. Net profit attributable to shareholders reached 134 million yuan, surging 136.8% year-on-year. Notably, revenue from the integrated financial client segment (F-end) and enterprise segment (B-end) corporate health business grew 30.2% year-on-year.

The company has deepened the development of its "medical-insurance synergy" model, continuously strengthening collaboration with Ping An Group's comprehensive financial business. Meanwhile, in the enterprise health management sector, the company has partnered with group members to create a "commercial insurance + health security entrustment + medical and health services" product system, vigorously expanding enterprise clients and achieving steady revenue growth with comprehensive improvement in profitability quality.

During the reporting period, F-end paying users numbered approximately 20 million, up 34.6% year-on-year. The company served over 3,500 paying enterprise clients, with B-end paying users exceeding 3.6 million, representing a 39.2% year-on-year increase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10